Super Biotic

Our Super Biotic is doctor-formulated to be complete, natural, bioavailable, and manufactured to pharmaceutical standards.

The following articles and studies, arranged in order of recency, provide information concerning the clinical basis for using Super Biotic.

Fujimori, S., et al. 2007. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease. J. Gastroenterol. Hepatol., 22 (8), 1199–1204. URL (abstract): (accessed 10.24.2007).

Boyle, R., et al. 2006. Probiotic use in clinical practice: What are the risks? Am. J. Clin. Nutr., 83, 1256–1264. URL (full text): (accessed 10.24.2007).

Falagas, M. et al. 2006. Probiotics for prevention of recurrent urinary tract infections in women: A review of the evidence from microbiological and clinical studies. Drugs, 66 (9), 1253–1261. URL (abstract): (accessed 10.04.2007).

Frankenfeld, C., et al. 2006. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas, 53 (3), 315–324. URL (abstract): (accessed 10.24.2007).

Parvez, S., et al. 2006. Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol., 100, 1171–1185. URL (full text): (accessed 10.24.2007).

Uehara, S., et al. 2006. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int. J. Antimicrob. Agents, 28, (Suppl. 1) S30–S34. URL (abstract):> (accessed 10.04.2007).

Marshall, B. 2005. The Lasker Awards: Celebrating scientific discovery. JAMA, 294, 1420–1421.

Adolfsson, O., et al. 2004. Yogurt and gut function. Am. J. Clin. Nutr., 80, 245–256. URL (full text): (accessed 10.24.2007).

Lin, H. 2004. Small intestinal bacterial overgrowth: A framework for understanding irritable bowel syndrome. JAMA, 292 (7), 852–858. URL (full text): (accessed 10.24.2007).

Marelli, G., et al. 2004. Lactobacilli for prevention of urogenital infections: A review. Eur. Rev. Med. Pharmacol. Sci., 8 (2), 87–95. URL (abstract): (accessed 10.04.2007).

Wang, K-Y., et al. 2004. Effects of ingesting Lactobacilus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr., 80, 737–741. URL (full text): (accessed 10.24.2007).

Halsted, C. 2003. Dietary supplements and functional foods: 2 sides of a coin? Am. J. Clin. Nutr., 77 (Suppl.), 1001S–1007S. URL (full text): (accessed 10.24.2007).

Fernández, M., et al. 2003. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J. Appl. Microbiol., 94, 449–455. URL (abstract): (accessed 10.24.2007).

Reid, G., et al. 2003. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial. FEMS Immunol. Med. Microbiol., 25 (20), 131–134. URL (abstract): (accessed 10.04.2007).

Reid, G., et al. 2003. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev., 16 (4), 658–672. URL: (full text): (accessed 10.24.2007).

Duggan, C., et al. 2002. Protective nutrients and functional foods for the gastrointestinal tract. Am. J. Clin. Nutr., 75, 789–808. URL (full text): (accessed 10.24.2007).

Ishikawa, H., et al. 2002. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J. Am. Coll. Nutr., 22 (1), 56–63. URL (full text): (accessed 10.24.2007).

Holzapfel, W., et al. 2001. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am. J. Clin. Nutr., 73 (Suppl.), 365S–373S. URL (full text): (accessed 10.24.2007).

Ishibashi, N., & Yamazaki, S. 2001. Probiotics and safety. Am. J. Clin. Nutr., 73 (Suppl.), 465S–470S. URL (full text): (accessed 10.24.2007).

Isolauri, E., et al. 2001. Probiotics: Effects on immunity. Am. J. Clin. Nutr., 73 (Suppl.), 444S–450S. URL (full text): (accessed 10.24.2007).

Isolauri, E. 2001. Probiotics in human disease. Am. J. Clin. Nutr., 73 (Suppl.), 1142S–1146S. URL (full text): (accessed 10.24.2007).

Marteau, P., et al. 2001. Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr., 73 (Suppl.), 430S–436S. URL (full text): (accessed 10.24.2007).

Saavedra, J. 2001. Clinical applications of probiotic agents. Am. J. Clin. Nutr., 73 (Suppl.), 1147S–1151S. URL (full text): (accessed 10.24.2007).

Vanderhoof, J. 2001. Probiotics: Future directions. Am. J. Clin. Nutr., 73 (Suppl.), 1152S–1155S. URL (full text): (accessed 10.24.2007).

Wollowski, I., et al. 2001. Protective role of probiotics and prebiotics in colon cancer. Am. J. Clin. Nutr., 73 (Suppl.), 451S–455S. URL (full text): (accessed 10.24.2007).

Roberfroid, M. 2000. Prebiotics and probiotics: Are they functional foods? Am. J. Clin. Nutr., 71 (Suppl.), 1682S–1687S. URL (full text): (accessed 10.24.2007).

Collins, M., & Gibson, G. 1999. Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr., 69 (Suppl.), 1052S–1057S. URL (full text): (accessed 10.24.2007).